文献速递湿疹皮炎与荨麻疹皮肤肿瘤

荨麻疹与癌症风险:丹麦人群队列研究

Urticaria and the risk of cancer: a Danish population-based cohort study.
PubMed 文献 · Br J Dermatol · 2024-01-01

该研究基于丹麦全国医疗数据库(1980-2022年),随访87 507例首次因荨麻疹就诊者(中位10.1年),发现随访第一年总体癌症风险升高(SIR 1.49),此后持续存在6%的风险增加(SIR 1.06);癌症分期与无荨麻疹者相似。

要点

  • 荨麻疹诊断后第一年癌症风险显著升高(SIR 1.49),尤其血液系统肿瘤。
  • 随访一年后仍存在6%的持续风险增加(SIR 1.06)。
  • 荨麻疹患者癌症分期与无荨麻疹者相似。

核心结论

  • 荨麻疹诊断时或其后第一年癌症风险大幅增加,此后持续存在6%的风险增加。

主要发现

  • 所有类型癌症总体SIR为1.09(95%CI 1.06-1.11),基于7788例观察 vs 7161例预期。
  • 随访第一年任何癌症风险为0.7%(95%CI 0.6-0.7),第一年诊断癌症588人(SIR 1.49,95%CI 1.38-1.62)。
  • 第一年后续年份诊断癌症7200人(SIR 1.06,95%CI 1.04-1.09)。
  • 随访第一年与非霍奇金淋巴瘤强相关(SIR 2.91,95%CI 1.92-4.23)。
  • 有 vs 无荨麻疹诊断者的癌症分期相似。

临床怎么用

  • 荨麻疹诊断后第一年应警惕癌症可能,尤其血液系统肿瘤,但总体风险较低。
  • 后续年份仍需关注持续轻度升高的癌症风险。

局限性

  • 观察性设计不能确立因果关系,短期风险升高可能部分源于诊断性检查。
  • 仅纳入医院接触的荨麻疹患者,可能低估轻症患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Urticaria has been tentatively linked to cancer, but epidemiological evidence supporting this link is sparse and conflicting. We conducted a population-based cohort study using healthcare databases covering the Danish population (January 1980-December 2022). We followed 87 507 people for a median of 10.1 years after their first hospital contact for urticaria. OBJECTIVES: To examine associations of a hospital diagnosis of urticaria with incident cancer. METHODS: We computed the absolute risk of cancer and standardized incidence ratios (SIRs) with 95% confidence intervals (CIs) standardized to Danish national cancer rates. In a cross-sectional analysis, we examined whether the extent of cancer spread differed between people with vs. without a previous urticaria diagnosis. RESULTS: The overall SIR for all types of cancer was 1.09 (95% CI 1.06-1.11) based on 7788 observed vs. 7161 expected cases. The risk for any cancer was 0.7% (95% CI 0.6-0.7) for the first year of follow-up. Cancer was diagnosed in 588 people with urticaria during the first year of follow-up (SIR 1.49, 95% CI 1.38-1.62) and in 7200 people thereafter (SIR 1.06, 95% CI 1.04-1.09). During the first year of follow-up, we found strong associations with haematological cancers (e.g. non-Hodgkin lymphoma; SIR 2.91, 95% CI 1.92-4.23). Cancer stage was similar in people with vs. without a previous urticaria diagnosis. CONCLUSIONS: At the time of urticaria diagnosis, or in the first year afterward, we found a large increase in the risk of cancer. In subsequent years, a persistent 6% increase in risk remained. Diagnostic efforts may partly explain the elevated short-term risk, but occult cancer may promote urticaria, or cancer and urticaria share common risk factors. Urticaria (also known as hives) is a common skin condition that causes wheals and/or angioedema (swelling). Approximately 9% of people will experience it in their lifetime. Urticaria is classified according to how long the symptoms last and is considered to be ‘chronic’ when the wheals and/or angioedema last for 6 weeks or more. Case studies have suggested that urticaria may be linked to cancers where the primary origin is not known. Only two other studies have compared different groups of people to estimate the risk and association between urticaria and cancer. Using healtcare information from Danish databases, we looked at the risk of cancer in people with urticaria and compared it with the general population. To do this, we followed 87,507 people for around 10 years after they first attended hospital for urticaria. We found that the risk of getting any cancer was 0.7% for the first year of follow-up. Cancer was diagnosed in 588 people with urticaria during the first year of follow-up and in 7,200 people after the first year. In the first year of follow-up, we found there was a strong association with blood cancers like non-Hodgkin lymphoma. Cancer stage was similar in people with a diagnosis of urticaria versus those without it. Our findings suggest that urticaria could be associated with a higher short-term risk of cancer, but the overall risk is low. Cancer of an unknown origin could promote urticaria, or cancer and urticaria share common risk factors.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Sørensen SBT, Farkas DK, Vestergaard C, et al. Urticaria and the risk of cancer: a Danish population-based cohort study. Br J Dermatol. 2024. PMID: 38924752. doi:10.1093/bjd/ljae264

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。